US WorldMeds: US WorldMeds gets FDA approval for childhood cancer drug
More than 700 people are diagnosed with neuroblastoma in the U.S. each year.
Read full article »
Founder & CEO
Paul Breckinridge Jones
US WorldMeds is a pharmaceutical company that develops and commercializes therapies for the treatment of idiopathic parkinson's disease.
Read more